Seastar Medical Holding Corporation (ICU)
NASDAQ (CM) NASDAQ (CM) Primary 
ASX 
ICU Investors Are Presented With The Chance To Spearhead The Securities Fraud Legal Case Against SeaStar Medical Holding Corporation With The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / July 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against SeaStar Medical Holding Corporation ("SeaStar" or "the Company") (NASDAQ:ICU) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 31, 2022 and March 26, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before September 6, 2024.
ICU SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Seastar Medical Holding Corp. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK CITY, NY / ACCESSWIRE / July 12, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Seastar Medical Holding Corp. ("Seastar" or "the Company") (NASDAQ:ICU)(NASDAQ:ICUCW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Seastar securities between October 31, 2022, and March 26, 2024, inclusive (the "Class Period").
ICU Investors Given Opportunity To Lead SeaStar Medical Holding Corporation Securities Fraud Legal Case With The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / July 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against SeaStar Medical Holding Corporation ("SeaStar" or "the Company") (NASDAQ:ICU) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 31, 2022 and March 26, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before September 6, 2024.
ICU Investors Are Presented With The Chance To Spearhead SeaStar Medical Holding Corporation Securities Fraud Legal Action With The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / July 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against SeaStar Medical Holding Corporation ("SeaStar" or "the Company") (NASDAQ:ICU) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 31, 2022 and March 26, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before September 6, 2024.
ICU INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Seastar Medical Holding Corp. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK CITY, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Seastar Medical Holding Corp. ("Seastar" or "the Company") (NASDAQ:ICU)(NASDAQ:ICUCW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Seastar securities between October 31, 2022, and March 26, 2024, inclusive (the "Class Period").
ICU Investors Are Presented With The Chance To Spearhead SeaStar Medical Holding Corporation Securities Fraud Legal Action With The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / July 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against SeaStar Medical Holding Corporation ("SeaStar" or "the Company") (NASDAQ:ICU) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 31, 2022 and March 26, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before September 6, 2024.
ICU SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Seastar Medical Holding Corp. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK CITY, NY / ACCESSWIRE / July 10, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Seastar Medical Holding Corp. ("Seastar" or "the Company") (NASDAQ:ICU)(NASDAQ:ICUCW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Seastar securities between October 31, 2022, and March 26, 2024, inclusive (the "Class Period").
1847 Reports 15.0% Increase in Revenue to $14.9 Million for the First Quarter of 2024
Gross profit increases 13.3% in Q1 2024 vs Q1 2023 NEW YORK, NY / ACCESSWIRE / May 16, 2024 / 1847 Holdings LLC("1847" or the "Company") (NYSE American:EFSH), a holding company specializing in identifying over-looked, deep value investment opportunities in middle market businesses, today provided a business update and reported financial results for the first quarter ended March 31, 2024. Q1 2024 Key Highlights Total Revenue was $14.9M in Q1 2024 compared to $13.0M in Q1 2023, a 15.0% year-over-year increase Gross profit was $5.6M in Q1 2024 compared to $4.9M in Q1 2023, a 13.3% year-over-year increase Executed Letter of Intent to Sell 1847 Cabinets Inc. for $27.6 Million Executed non-binding LOI to acquire a large, established millwork, cabinetry and door manufacturer based in Las Vegas, NV with revenues of $28.6 million, with a purchase price of $16.75 million which represents approximately 3.2x 2023 EBITDA Announced ICU Eyewear subsidiary diversified manufacturing to reduce production costs and fortify supply chain Announced ICU Eyewear subsidiary's strategic expansion of partnerships, adding 300 new locations with leading US retailer Completed refinancing and upsizing of $15 million revolving credit facility for ICU Eyewear subsidiary Expanded Wolo Manufacturing Corp subsidiary into India through supply chain diversification program Restructured promissory notes to non-dilutive debt instruments Divested Asien's Appliance business, significantly enhancing balance sheet Mr.
